{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:45:19Z","timestamp":1791161119310,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T00:00:00Z","timestamp":1353369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1038\/bjc.2012.489","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T10:54:25Z","timestamp":1353495265000},"page":"1917-1924","source":"Crossref","is-referenced-by-count":71,"title":["Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial \u2013 the HPV FOCAL Study"],"prefix":"10.1038","volume":"107","author":[{"given":"G S","family":"Ogilvie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"van Niekerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T G","family":"Ehlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L W","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G C E","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E L","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Coldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,20]]},"reference":[{"key":"BFbjc2012489_CR1","doi-asserted-by":"publisher","first-page":"c1804","DOI":"10.1136\/bmj.c1804","volume":"340","author":"A Anttila","year":"2010","unstructured":"Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, Malila N, Nieminen P (2010) Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 340: c1804","journal-title":"BMJ"},{"key":"BFbjc2012489_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrclinonc.2010.96","volume":"7","author":"PE Castle","year":"2010","unstructured":"Castle PE (2010) Screening: HPV testing for cervical cancer: the good, the bad, and the ugly. Nat Rev Clin Oncol 7: 364\u2013365","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 10","key":"BFbjc2012489_CR3","doi-asserted-by":"publisher","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","volume":"26","author":"J Cuzick","year":"2008","unstructured":"Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ (2008) Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26 (Suppl 10): K29\u2013K41","journal-title":"Vaccine"},{"key":"BFbjc2012489_CR4","doi-asserted-by":"publisher","first-page":"a1754","DOI":"10.1136\/bmj.a1754","volume":"337","author":"J Dillner","year":"2008","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T Joint European CS (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337: a1754","journal-title":"BMJ"},{"key":"BFbjc2012489_CR5","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/ijc.24634","volume":"125","author":"S Franceschi","year":"2009","unstructured":"Franceschi S, Cuzick J, Herrero R, Dillner J, Wheeler CM (2009) EUROGIN 2008 roadmap on cervical cancer prevention. Int J Cancer 125: 2246\u20132255","journal-title":"Int J Cancer"},{"key":"BFbjc2012489_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.vaccine.2007.11.069","volume":"2008","author":"EL Franco","year":"2008","unstructured":"Franco EL, Cuzick J (2008) Cervical cancer screening following prophylactic human papillomavirus vaccination. Vaccine 2008: 16\u201323","journal-title":"Vaccine"},{"key":"BFbjc2012489_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","volume":"367","author":"M Kyrgiou","year":"2006","unstructured":"Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E (2006) Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367: 489\u2013498","journal-title":"Lancet"},{"key":"BFbjc2012489_CR8","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/jnci\/djp367","volume":"101","author":"M Leinonen","year":"2009","unstructured":"Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A (2009) Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 101: 1612\u20131623","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2012489_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2407-10-111","volume":"10","author":"GS Ogilvie","year":"2010","unstructured":"Ogilvie GS, van Niekerk DJ, Krajden M, Martin RE, Ehlen TG, Ceballos K, Peacock SJ, Smith LW, Kan L, Cook DA, Mei W, Stuart GC, Franco EL, Coldman AJ (2010) A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer 10: 111","journal-title":"BMC Cancer"},{"key":"BFbjc2012489_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","volume":"335","author":"G Ronco","year":"2007","unstructured":"Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla PP, Naldoni C, Ghiringhello B, Giorgi-Rossi P, Minucci D, Parisio F, Pojer A, Schiboni ML, Sintoni C, Zorzi M, Segnan N, Confortini M (2007) Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. [see comment]. BMJ 335: 28","journal-title":"BMJ"},{"key":"BFbjc2012489_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","volume":"11","author":"G Ronco","year":"2010","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11: 249\u2013257","journal-title":"Lancet Oncol"},{"key":"BFbjc2012489_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","volume":"7","author":"G Ronco","year":"2006","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Dalla PP, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J New Technologies for Cervical Cancer Screening Working Group New Technologies for Cervical Cancer Screening Working Group (2006) Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 7: 547\u2013555","journal-title":"Lancet Oncol"},{"key":"BFbjc2012489_CR13","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1001\/jama.2009.1569","volume":"302","author":"AG Siebers","year":"2009","unstructured":"Siebers AG, Klinkhamer PJJM, Grefte JMM, Massuger LFAG, Vedder JEM, Beijers-Broos A, Bulten J, Arbyn M (2009) Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized trial. JAMA 302: 1757\u20131764","journal-title":"JAMA"},{"key":"BFbjc2012489_CR14","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N Forum Group, Bethesda 2001 Workshop (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287: 2114\u20132119","journal-title":"JAMA"},{"key":"BFbjc2012489_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12\u201319","journal-title":"J Pathol"},{"issue":"10","key":"BFbjc2012489_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","volume":"155","author":"EP Whitlock","year":"2011","unstructured":"Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU (2011) Liquid-based cytology and Human Papillomavirus testing to screen for cervical cancer: a systematic review for the US Preventive Services Task Force. Ann Intern Med 155 (10): 687\u2013697,, W214-5","journal-title":"Ann Intern Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012489","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:11:37Z","timestamp":1684415497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,20]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["BFbjc2012489"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.489","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,20]]}}}